The Role of Neurotrophins in Inflammation and Allergy

Vitamins and Hormones

Volumn 104, Issue , 2017, Pages 313-341

  Manti, S ^a   Brown, P ^a   Perez, M K ^a   Piedimonte, G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Allergy; Inflammation; Neurogenic inflammation; Neuropeptides; Neurotrophins

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

AGONISTS; ANIMAL; BIOLOGICAL MODEL; EOSINOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE; MACROPHAGE; MAST CELL; METABOLISM; NERVE CELL; NEUROGENIC INFLAMMATION; PATHOLOGY;

ANIMALS; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; LYMPHOCYTES; MACROPHAGES; MAST CELLS; MODELS, IMMUNOLOGICAL; MODELS, NEUROLOGICAL; NERVE GROWTH FACTORS; NEUROGENIC INFLAMMATION; NEURONS; RECEPTORS, NERVE GROWTH FACTOR;

EID: 85007353604     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2016.10.010     Document Type: Chapter

References (105)

1. Andiappan, A.K., et al. Genetic variation in BDNF is associated with allergic asthma and allergic rhinitis in an ethnic Chinese population in Singapore. Cytokine 56:2 (2011), 218–223.
2. Barada, K.A., et al. Up-regulation of nerve growth factor and interleukin-10 in inflamed and non-inflamed intestinal segments in rats with experimental colitis. Cytokine 37:3 (2007), 236–245.
3. Barde, Y.A., Edgar, D., Thoenen, H., Purification of a new neurotrophic factor from mammalian brain. The EMBO Journal 1:5 (1982), 549–553.
4. Barouch, R., et al. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. Journal of Neuroimmunology 103:2 (2000), 112–121.
5. Bibel, M., Barde, Y.A., Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes & Development 14:23 (2000), 2919–2937.
6. Blochl, A., Blochl, R., A cell-biological model of p75NTR signaling. Journal of Neurochemistry 102:2 (2007), 289–305.
7. Bonini, S., et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proceedings of the National Academy of Sciences of the United States of America 93:20 (1996), 10955–10960.
8. Bonini, S., et al. Nerve growth factor: Neurotrophin or cytokine?. International Archives of Allergy and Immunology 131:2 (2003), 80–84.
9. Braun, A., et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. European Journal of Immunology 28:10 (1998), 3240–3251.
10. Braun, A., et al. Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. American Journal of Respiratory Cell and Molecular Biology 21:4 (1999), 537–546.
11. Braun, A., et al. Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. British Journal of Pharmacology 141:3 (2004), 431–440.
12. Brown, P.M., Schneeberger, D.L., Piedimonte, G., Biomarkers of respiratory syncytial virus (RSV) infection: Specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatric Respiratory Reviews 16:4 (2015), 232–240.
13. Bullock, E.D., Johnson, E.M. Jr., Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. The Journal of Biological Chemistry 271:44 (1996), 27500–27508.
14. Caporali, A., Emanueli, C., Cardiovascular actions of neurotrophins. Physiological Reviews 89:1 (2009), 279–308.
15. Chao, M.V., Neurotrophins and their receptors: A convergence point for many signalling pathways. Nature Reviews. Neuroscience 4:4 (2003), 299–309.
16. Chao, M.V., Lee, F.S., Neurotrophin survival signaling mechanisms. Journal of Alzheimer's Disease 6:6 Suppl. (2004), S7–S11.
17. Chen, Y.L., et al. Small interfering RNA targeting nerve growth factor alleviates allergic airway hyperresponsiveness. Molecular Therapy. Nucleic Acids, 3, 2014, e158.
18. Costello, R.W., et al. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. The American Journal of Physiology 273:1 Pt. 1 (1997), L93–L103.
19. de Vries, A., et al. Airway hyper-responsiveness in allergic asthma in guinea-pigs is mediated by nerve growth factor via the induction of substance P: A potential role for trkA. Clinical and Experimental Allergy 36:9 (2006), 1192–1200.
20. Dechant, G., Barde, Y.A., The neurotrophin receptor p75(NTR): Novel functions and implications for diseases of the nervous system. Nature Neuroscience 5:11 (2002), 1131–1136.
21. Dunzendorfer, S., et al. Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation 10:4 (2002), 217–223.
22. Esche, C., de Benedetto, A., Beck, L.A., Keratinocytes in atopic dermatitis: Inflammatory signals. Current Allergy and Asthma Reports 4:4 (2004), 276–284.
23. Fischer, T.C., et al. Pan-neurotrophin receptor p75NTR expression is strongly induced in lesional atopic mast cells. Clinical and Experimental Allergy 38:7 (2008), 1168–1173.
24. Foster, E.L., et al. Eosinophils increase neuron branching in human and murine skin and in vitro. PloS One, 6(7), 2011, e22029.
25. Frade, J.M., Barde, Y.A., Nerve growth factor: Two receptors, multiple functions. Bioessays 20:2 (1998), 137–145.
26. Freund-Michel, V., Frossard, N., The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacology & Therapeutics 117:1 (2008), 52–76.
27. Grewe, M., et al. Neurotrophin-4 production by human epidermal keratinocytes: Increased expression in atopic dermatitis. The Journal of Investigative Dermatology 114:6 (2000), 1108–1112.
28. Hallbook, F., Evolution of the vertebrate neurotrophin and Trk receptor gene families. Current Opinion in Neurobiology 9:5 (1999), 616–621.
29. Horigome, K., et al. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. The Journal of Biological Chemistry 268:20 (1993), 14881–14887.
30. Huang, E.J., Reichardt, L.F., Neurotrophins: Roles in neuronal development and function. Annual Review of Neuroscience 24 (2001), 677–736.
31. Huang, E.J., Reichardt, L.F., Trk receptors: Roles in neuronal signal transduction. Annual Review of Biochemistry 72 (2003), 609–642.
32. Huang, L.W., et al. Inhibition of nerve growth factor/tyrosine kinase receptor A signaling ameliorates airway remodeling in chronic allergic airway inflammation. European Review for Medical and Pharmacological Sciences 19:12 (2015), 2261–2268.
33. Iacaruso, M.F., et al. Structural model for p75(NTR)-TrkA intracellular domain interaction: A combined FRET and bioinformatics study. Journal of Molecular Biology 414:5 (2011), 681–698.
34. Iwasaki, A., Mucosal dendritic cells. Annual Review of Immunology 25 (2007), 381–418.
35. Jacobsen, E.A., et al. Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation?. The Journal of Allergy and Clinical Immunology 119:6 (2007), 1313–1320.
36. Jesenak, M., et al. Val66Met polymorphism in the BDNF gene in children with bronchial asthma. Pediatric Pulmonology 50:7 (2015), 631–637.
37. Jiang, Y., et al. TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kappa B pathways. Molecular Immunology 45:6 (2008), 1557–1566.
38. Jin, P., et al. A functional brain-derived neurotrophic factor (BDNF) gene variant increases the risk of moderate-to-severe allergic rhinitis. The Journal of Allergy and Clinical Immunology 135:6 (2015), 1486–1493 e8.
39. Kanbe, N., et al. Nerve growth factor prevents apoptosis of cord blood-derived human cultured mast cells synergistically with stem cell factor. Clinical and Experimental Allergy 30:8 (2000), 1113–1120.
40. Kassel, O., et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clinical and Experimental Allergy 31:9 (2001), 1432–1440.
41. Kay, A.B., Asthma and inflammation. The Journal of Allergy and Clinical Immunology 87:5 (1991), 893–910.
42. Kilic, A., et al. Nerve growth factor induces type III collagen production in chronic allergic airway inflammation. The Journal of Allergy and Clinical Immunology 128:5 (2011), 1058–1066 e1–e4.
43. Kobayashi, H., et al. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 99:6 (2002), 2214–2220.
44. Kritas, S.K., et al. Nerve growth factor interactions with mast cells. International Journal of Immunopathology and Pharmacology 27:1 (2014), 15–19.
45. Kubanov, A.A., Katunina, O.R., Chikin, V.V., Expression of neuropeptides, neurotrophins, and neurotransmitters in the skin of patients with atopic dermatitis and psoriasis. Bulletin of Experimental Biology and Medicine 159:3 (2015), 318–322.
46. Lee, N.A., Gelfand, E.W., Lee, J.J., Pulmonary T cells and eosinophils: Coconspirators or independent triggers of allergic respiratory pathology?. The Journal of Allergy and Clinical Immunology 107:6 (2001), 945–957.
47. Lee, R., et al. Regulation of cell survival by secreted proneurotrophins. Science 294:5548 (2001), 1945–1948.
48. Levi-Montalcini, R., The nerve growth factor 35 years later. Science 237:4819 (1987), 1154–1162.
49. Lewin, G.R., Barde, Y.A., Physiology of the neurotrophins. Annual Review of Neuroscience 19 (1996), 289–317.
50. Liezmann, C., Klapp, B., Peters, E.M., Stress, atopy and allergy: A re-evaluation from a psychoneuroimmunologic perspective. Dermato-endocrinology 3:1 (2011), 37–40.
51. Longo, F.M., Massa, S.M., Small-molecule modulation of neurotrophin receptors: A strategy for the treatment of neurological disease. Nature Reviews. Drug Discovery 12:7 (2013), 507–525.
52. Lu, B., Pang, P.T., Woo, N.H., The yin and yang of neurotrophin action. Nature Reviews. Neuroscience 6:8 (2005), 603–614.
53. Matsumura, S., et al. Th2 cytokines enhance TrkA expression, upregulate proliferation, and downregulate differentiation of keratinocytes. Journal of Dermatological Science 78:3 (2015), 215–223.
54. Michel, T., et al. Increased Th2 cytokine secretion, eosinophilic airway inflammation, and airway hyperresponsiveness in neurturin-deficient mice. Journal of Immunology 186:11 (2011), 6497–6504.
55. Muller, G.C., et al. Plasma brain-derived neurotrophic factor levels are associated with clinical severity in school age children with asthma. Clinical and Experimental Allergy 40:12 (2010), 1755–1759.
56. Nakahashi, T., et al. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Letters 470:2 (2000), 113–117.
57. Nassenstein, C., et al. Neuro-immune interaction in allergic asthma: Role of neurotrophins. Biochemical Society Transactions 34:Pt. 4 (2006), 591–593.
58. Nockher, W.A., Renz, H., Neurotrophins in allergic diseases: From neuronal growth factors to intercellular signaling molecules. The Journal of Allergy and Clinical Immunology 117:3 (2006), 583–589.
59. Noga, O., et al. The influence of inhalative corticosteroids on circulating nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in allergic asthmatics. Clinical and Experimental Allergy 31:12 (2001), 1906–1912.
60. Noga, O., et al. Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clinical and Experimental Allergy 32:9 (2002), 1348–1354.
61. Noga, O., et al. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor. Clinical and Experimental Allergy 37:11 (2007), 1701–1708.
62. Ogawa, H., et al. Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA. Clinical and Experimental Allergy 42:3 (2012), 460–470.
63. Othumpangat, S., et al. NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection. PloS One, 4(7), 2009, e6444.
64. Pan, P., Tan, H., Li, H., Nerve growth factor promotes the maturation and cytokine release of dendritic cells induced by ovalbumin with low-dose lipopolysaccharide via the NF-kB pathway. American Journal of Respiratory and Critical Care Medicine, 193, 2016, A4928.
65. Patel, K.R., et al. Mast cell-derived neurotrophin 4 mediates allergen-induced airway hyperinnervation in early life. Mucosal Immunology 9:6 (2016), 1466–1476.
66. Path, G., et al. Augmentation of allergic early-phase reaction by nerve growth factor. American Journal of Respiratory and Critical Care Medicine 166:6 (2002), 818–826.
67. Peters, E.M., et al. Neuropeptide control mechanisms in cutaneous biology: Physiological and clinical significance. The Journal of Investigative Dermatology 126:9 (2006), 1937–1947.
68. Peters, E.M., et al. Nerve growth factor partially recovers inflamed skin from stress-induced worsening in allergic inflammation. The Journal of Investigative Dermatology 131:3 (2011), 735–743.
69. Peters, E.M., et al. The neuroimmune connection interferes with tissue regeneration and chronic inflammatory disease in the skin. Annals of the New York Academy of Sciences 1262 (2012), 118–126.
70. Pons, F., et al. Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. European Journal of Pharmacology 428:3 (2001), 365–369.
71. Pouliot, P., et al. Interleukin-4 production by human alveolar macrophages. Clinical and Experimental Allergy 35:6 (2005), 804–810.
72. Prakash, Y.S., Thompson, M.A., Pabelick, C.M., Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2 + in human airway smooth muscle. American Journal of Respiratory Cell and Molecular Biology 41:5 (2009), 603–611.
73. Prakash, Y., et al. Neurotrophins in lung health and disease. Expert Review of Respiratory Medicine 4:3 (2010), 395–411.
74. Prencipe, G., et al. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA. Journal of Immunology 192:7 (2014), 3345–3354.
75. Qin, Q., et al. Lung dendritic cells undergo maturation and polarization towards a T helper type 2-stimulating phenotype in a mouse model of asthma: Role of nerve growth factor. Experimental and Therapeutic Medicine 8:5 (2014), 1402–1408.
76. Raap, U., Wardlaw, A.J., A new paradigm of eosinophil granulocytes: Neuroimmune interactions. Experimental Dermatology 17:9 (2008), 731–738.
77. Raap, U., et al. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. Journal of Allergy and Clinical Immunology 115:6 (2005), 1268–1275.
78. Raap, U., et al. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy 61:12 (2006), 1416–1418.
79. Raychaudhuri, S.P., Jiang, W.Y., Farber, E.M., Psoriatic keratinocytes express high levels of nerve growth factor. Acta Dermato-Venereologica 78:2 (1998), 84–86.
80. Reichardt, L.F., Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 361:1473 (2006), 1545–1564.
81. Ricci, A., et al. Neurotrophins and neurotrophin receptors in human pulmonary arteries. Journal of Vascular Research 37:5 (2000), 355–363.
82. Ricci, A., et al. Elevated neurotrophin and neurotrophin receptor expression in spontaneously hypertensive rat lungs. Growth Factors 22:3 (2004), 195–205.
83. Rodriguez-Tebar, A., Dechant, G., Barde, Y.A., Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron 4:4 (1990), 487–492.
84. Rost, B., et al. Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. Regulatory Peptides 124:1-3 (2005), 19–25.
85. Samah, B., Porcheray, F., Gras, G., Neurotrophins modulate monocyte chemotaxis without affecting macrophage function. Clinical and Experimental Immunology 151:3 (2008), 476–486.
86. Sanico, A.M., et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. American Journal of Respiratory and Critical Care Medicine 161:5 (2000), 1631–1635.
87. Shooter, E.M., Early days of the nerve growth factor proteins. Annual Review of Neuroscience 24 (2001), 601–629.
88. Siebenhaar, F., et al. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. The Journal of Allergy and Clinical Immunology 121:4 (2008), 955–961.
89. Taniuchi, S., et al. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. Journal of Dermatological Science 26:1 (2001), 79–82.
90. Tominaga, M., et al. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. Journal of Dermatological Science 46:3 (2007), 199–210.
91. Townley, S.L., et al. Nerve growth factor, neuropeptides, and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice. The Journal of Investigative Dermatology 118:3 (2002), 396–401.
92. Toyoda, M., et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. The British Journal of Dermatology 147:1 (2002), 71–79.
93. Toyoda, M., et al. Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients. Clinical and Experimental Allergy 33:7 (2003), 950–955.
94. Undem, B.J., et al. Neural integration and allergic disease. The Journal of Allergy and Clinical Immunology 106:5 Suppl. (2000), S213–S220.
95. Urfer, R., et al. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors. The Journal of Biological Chemistry 273:10 (1998), 5829–5840.
96. Veres, T.Z., et al. Dendritic cell-nerve clusters are sites of T cell proliferation in allergic airway inflammation. The American Journal of Pathology 174:3 (2009), 808–817.
97. Virchow, J.C., et al. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. American Journal of Respiratory and Critical Care Medicine 158:6 (1998), 2002–2005.
98. Walsh, G.M., Eosinophil apoptosis: Mechanisms and clinical relevance in asthmatic and allergic inflammation. British Journal of Haematology 111:1 (2000), 61–67.
99. Wang, S., et al. p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells. The American Journal of Pathology 157:4 (2000), 1247–1258.
100. Wang, J.Y., et al. Association between a functional single nucleotide polymorphism in the brain-derived neurotrophic factor gene and risk of child asthma. Genetics and Molecular Research 14:4 (2015), 16233–16240.
101. Watanabe, T., et al. Brain-derived neurotrophic factor expression in asthma. Association with severity and type 2 inflammatory processes. American Journal of Respiratory Cell and Molecular Biology 53:6 (2015), 844–852.
102. Wiesmann, C., de Vos, A.M., Nerve growth factor: Structure and function. Cellular and Molecular Life Sciences 58:5-6 (2001), 748–759.
103. Xia, Q., et al. Role of nerve growth factor in differentiation of dendritic cells. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 40:8 (2015), 829–836.
104. Yang, Y.G., et al. Nerve growth factor exacerbates allergic lung inflammation and airway remodeling in a rat model of chronic asthma. Experimental and Therapeutic Medicine 6:5 (2013), 1251–1258.
105. Ye, Y.L., et al. Dermatophagoides pteronyssinus 2 regulates nerve growth factor release to induce airway inflammation via a reactive oxygen species-dependent pathway. American Journal of Physiology. Lung Cellular and Molecular Physiology 300:2 (2011), L216–L224.